Companies / New York / Ensho Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Ensho Therapeutics? Who to reach and why now

Headquartered in Morris Plains, New York, Ensho Therapeutics is a private biotechnology company, founded 2024. It raised $7.3M in Oct 2026 and its filings name 7 officers. Everything below links to the record it came from.

Private company · Biotechnology · New York

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerDanielle FrySEC filing, Oct 2026Named officer in the filing; part of the buying group
Chief Technology OfficerArash RassoulpourSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerCarlos SolorzanoSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerEric PhamSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerGerhard HagnSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerNeena Bitritto-GargSEC filing, Oct 2026Technology and tooling decisions
Chief Technology OfficerTariq KassumSEC filing, Oct 2026Technology and tooling decisions
For sellersWhy Ensho Therapeutics is worth a call this quarterBuy Window: open · new funding Oct 2026
$7.3M

Raised

Equity raise reported to the SEC, Oct 2026. Money arrives before the spending plan does.

Capital
$27.3M9 months

Back-to-back raises

2 equity raises in 9 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
7officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Ensho Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Ensho Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Oct 2, 2026Raised $7.3M in equity from 7 investorsCapitalSEC filing
Jan 20, 2026Raised $20M in equity from 9 investorsCapitalSEC filing

Email format

Ensho Therapeutics uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach Ensho Therapeutics with emails that land

Lakewave finds the right people at Ensho Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Ensho Therapeutics with a free trial →

About Ensho Therapeutics

HeadquartersMorris Plains, New York, per the filing address
Industry groupBiotechnology
Founded2024, DELAWARE
OwnershipPrivate company
Raise history$20M (Jan 2026) · $7.3M (Oct 2026)
Lakewave Rising17 · 1 kinds of evidence · rank in New York after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Rapalogix Health · 10Cresilon · 3See all 2 with a free trial →

Questions people ask

Did Ensho Therapeutics raise funding in 2026?

Yes. Ensho Therapeutics reported a $7.3M equity raise to the SEC on Oct 2, 2026 with 7 investors.

Who runs Ensho Therapeutics?

The company's SEC filing, Oct 2026 names Danielle Fry (Executive Officer) among its officers.

Where is Ensho Therapeutics headquartered?

Morris Plains, New York, per the address on its SEC filing.

What is Ensho Therapeutics's email format?

Ensho Therapeutics uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at Ensho Therapeutics use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.